Study on the new target of the individual treatment of breast cancer by argininosuccinate synthetase 1

Xiangnan Ye,Jingxuan Wang,Qingyuan Zhang
DOI: https://doi.org/10.3969/j.issn.1672-4992.2017.14.041
2017-01-01
Journal of Modern Oncology
Abstract:Amino acid metabolism has a pivotal role in cellular physiology as it is being involved in numerous cellular metabolic and signaling pathways.Argininosuccinate synthetase 1 is a key enzyme in the urea cycle.ASS1 deficiency or low expression of breast cancer cells resulted in arginine deficiency,so reducing or decreasing the content of arginine can effectively inhibit tumor progression.Experimental results show that recombinant pegylated ADI(ADI-PEG20) promotes arginine into citrulline,thereby reducing the content of arginine.mTOR inhibitors can be used to inhibit the phosphorylation of CAD,and ASS1 competed with substrate aspartic acid to inhibit the growth and proliferation of breast cancer cells.ASS1 detection will become a new anti-cancer target.
What problem does this paper attempt to address?